ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,172.15
0.63%
Dow Jones
38,225.66
0.85%
Gold vs US Dollar
2,302.525
-0.94%
Brent Oil
83.63
0.11%
Bitcoin
59,121.20
1.52%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lipocine Inc (LPCN)

  7. Lipocine Inc (LPCN) News

Lipocine (LPCN)

Lipocine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LPCN
DateTimeSourceHeadlineSymbolCompany
01/05/202413:00PR Newswire (US)Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154NASDAQ:LPCNLipocine Inc
11/04/202412:00PR Newswire (US)Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityNASDAQ:LPCNLipocine Inc
28/03/202412:00PR Newswire (US)Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisNASDAQ:LPCNLipocine Inc
25/03/202412:00PR Newswire (US)Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
07/03/202422:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
07/03/202413:00PR Newswire (US)Lipocine Announces Financial Results for the Full Year Ended December 31, 2023NASDAQ:LPCNLipocine Inc
07/03/202411:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
07/03/202411:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LPCNLipocine Inc
06/03/202413:00PR Newswire (US)Lipocine to Present at 36th Annual Roth ConferenceNASDAQ:LPCNLipocine Inc
06/03/202411:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
12/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
06/02/202413:00PR Newswire (US)Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
02/02/202413:00PR Newswire (US)Lipocine Announces Continued Commercialization of TLANDO® through Verity PharmaceuticalsNASDAQ:LPCNLipocine Inc
18/01/202413:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
18/01/202413:00PR Newswire (US)Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and CanadaNASDAQ:LPCNLipocine Inc
19/12/202315:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
19/12/202313:00PR Newswire (US)Lipocine to Present at Biotech Showcase 2024NASDAQ:LPCNLipocine Inc
22/11/202321:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LPCNLipocine Inc
13/11/202319:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
13/11/202319:45PR Newswire (US)Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
08/11/202318:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
08/11/202314:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
08/11/202313:00PR Newswire (US)Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023NASDAQ:LPCNLipocine Inc
01/11/202313:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
01/11/202312:00PR Newswire (US)Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
26/10/202314:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
26/10/202313:00PR Newswire (US)Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum DepressionNASDAQ:LPCNLipocine Inc
24/10/202300:00PR Newswire (US)Lipocine to Present at the H.C. Wainwright Annual NASH Investor ConferenceNASDAQ:LPCNLipocine Inc
06/10/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
19/09/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
 Showing the most relevant articles for your search:NASDAQ:LPCN

Your Recent History

LSE
TERN
Tern
LSE
SCE
Surface Transforms
LSE
BIRD
Blackbird
LSE
AAU
Ariana Resources
LSE
IES
Invinity Energy Systems
LSE
SOLG
Solgold
LSE
SCLP
Scancell
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
GKP
Gulf Keystone Petroleum
LSE
GFM
Griffin Mining
LSE
LLOY
Lloyds Banking
LSE
AAZ
Anglo Asian Mining
LSE
BT.A
Bt
LSE
PANR
Pantheon Resources
LSE
I3E
I3 Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved